Windlas Biotech informs about outcome of board meeting

12 Aug 2025 Evaluate

In terms of Regulation 30 and 33 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Windlas Biotech has informed that the Board of Directors of the Company in its meeting held on August 12, 2025, has considered and approved the following: 1. the unaudited (Standalone & Consolidated) financial results for the Quarter ended June 30, 2025; 2. the unaudited financial results along with the Limited Review Reports thereon received from the Statutory Auditors (J C Bhalla & Co, Chartered Accountants) are enclosed as Annexure. The meeting of the Board of Directors commenced at 2.00 pm and concluded at 2.55 pm.

The above information is a part of company’s filings submitted to BSE.


Windlas Biotech Share Price

839.90 7.20 (0.86%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×